Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association.

作者: Robert J Adams , Marc I Chimowitz , Joseph S Alpert , Issam A Awad , Manuel D Cerqueria

DOI: 10.1161/01.CIR.0000090444.87006.CF

关键词:

摘要: Stroke and myocardial infarction (MI) share common risk factors pathological mechanisms, coronary artery disease (CHD) is an important cause of death in patients with cerebrovascular disease. This Scientific Statement addresses issues management the relatively healthy patient brain ischemia (a transient ischemic attack [TIA] or stroke) who does not have recognized CHD but often has addition to having had a TIA stroke that indicate increased likelihood disability from cardiac future. should be confused official American College Cardiology (ACC)/American Heart Association (AHA) practice guidelines. The reader referred ACC/AHA guidelines for symptomatic CHD1 Chest Physicians (ACCP)2 (ASA)3–5 evaluation causes stroke, which are related separate issues. Several small studies shown high prevalence asymptomatic CHD.6–8 Rokey et al6 performed exercise thallium (Tl) 201 scintigraphy radionuclide ventriculography on 50 consecutive stroke. Sixteen symptoms suggestive ischemia; other 34 were asymptomatic. results perfusion imaging abnormal 15 16 (94%) 14 (41%). Twenty-two underwent angiography, showed severe (≥70% stenosis lumen ≥1 artery) 18 (10 13 8 9 patients). Twelve multivessel disease. In study by Di Pasquale al,7 83 minor no …

参考文章(99)
Enlimomab Acute Stroke Trial Investigators, None, Use of anti-ICAM-1 therapy in ischemic stroke Results of the Enlimomab Acute Stroke Trial Neurology. ,vol. 57, pp. 1428- 1434 ,(2001) , 10.1212/WNL.57.8.1428
Kim A Eagle, Robert A Guyton, Ravin Davidoff, Gordon A Ewy, James Fonger, Timothy J Gardner, John Parker Gott, Howard C Herrmann, Robert A Marlow, William Nugent, Gerald T O’Connor, Thomas A Orszulak, Richard E Rieselbach, William L Winters, Salim Yusuf, Raymond J Gibbons, Joseph S Alpert, Kim A Eagle, Timothy J Gardner, Arthur Garson Jr, Gabriel Gregoratos, Richard O Russell, Thomas J Ryan, Sidney C Smith Jr, None, ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: Executive Summary and Recommendations A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) Circulation. ,vol. 100, pp. 1464- 1480 ,(1999) , 10.1161/01.CIR.100.13.1464
A. Heyman, W. E. Wilkinson, B. J. Hurwitz, C. S. Haynes, C. M. Utley, R. A. Rosati, J. G. Burch, T. B. Gore, Risk of ischemic heart disease in patients with TIA Neurology. ,vol. 34, pp. 626- 626 ,(1984) , 10.1212/WNL.34.5.626
R L Sacco, P A Wolf, W B Kannel, P M McNamara, Survival and recurrence following stroke. The Framingham study. Stroke. ,vol. 13, pp. 290- 295 ,(1982) , 10.1161/01.STR.13.3.290
Hans Christoph Diener, Erich Bernd Ringelstein, Rüdiger von Kummer, Hans Dieter Langohr, Heiko Bewermeyer, Helmut Landgraf, Michael Hennerici, Dieter Welzel, Michael Gräve, Joachim Brom, Gottfried Weidinger, Treatment of Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin Results of the TOPAS Trial Stroke. ,vol. 32, pp. 22- 29 ,(2001) , 10.1161/01.STR.32.1.22
Roxann Rokey, Loren A. Rolak, Yadollah Harati, N. Kutka, Mario S. Verani, Coronary artery disease in patients with cerebrovascular disease: a prospective study. Annals of Neurology. ,vol. 16, pp. 50- 53 ,(1984) , 10.1002/ANA.410160110
W.T. Longstreth, C. Bernick, A. Fitzpatrick, M. Cushman, L. Knepper, J. Lima, C.D. Furberg, Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study Neurology. ,vol. 56, pp. 368- 375 ,(2001) , 10.1212/WNL.56.3.368